Going the Extra Mile - or Hundred - for Patients
In this month's episode, we'll hear from one extraordinary oncology nurse who ran 100 miles for cancer research.
A passion for running and helping her patients has led Angela Hammack, BSN, RN, OCN, to do great things. In 2017, Hammack, a charge nurse and clinical educator with Jackson Oncology Associates, ran a 100-mile race for cancer research and patient care. Her efforts continued after that, and to-date, she has raised over $100,000 for the cause.
For this month’s episode, we’ll hear from Hammack—who was also a finalist for CURE’s 2019 Extraordinary Healer Award—about what keeps her motivated.
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC
Published: December 20th 2024 | Updated: December 20th 2024The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.
